Treatment of pathologic spinal fractures with combined radiofrequency ablation and balloon kyphoplasty
© Katonis et al; licensee BioMed Central Ltd. 2009
Received: 2 August 2009
Accepted: 16 November 2009
Published: 16 November 2009
In oncologic patients with metastatic spinal disease, the ideal treatment should be well tolerated, relieve the pain, and preserve or restore the neurological function.
The combination of fluoroscopic guided radiofrequency ablation (RFA) and kyphoplasty may fulfill these criteria.
We describe three pathological vertebral fractures treated with a combination of fluoroscopic guided RFA and kyphoplasty in one session: a 62-year-old man suffering from a painful L4 pathological fracture due to a plasmocytoma, a 68-year-old man with a T12 pathological fracture from metastatic hepatocellular carcinoma, and a 71-year-old man with a Th12 and L1 pathological fracture from multiple myeloma.
The choice of patients was carried out according to the classification of Tomita. Visual analog score (VAS) and Oswestry disability index (ODI) were used for the evaluation of the functional outcomes. The treatment was successful in all patients and no complications were reported. The mean follow-up was 6 months. Marked pain relief and functional restoration was observed.
In our experience the treatment of pathologic spinal fractures with combined radiofrequency ablation and balloon kyphoplasty is safe and effective for immediate pain relief in painful spinal lesions in neurologically intact patients.
The spine is the most frequent site of bone metastases. Spinal involvement may occur in up to 40% of patients with cancer and approximately 70% of patients with cancer have evidence of metastatic disease at the time of their deaths . As many as 75% of vertebral metastases occur in patients with carcinoma of breast, kidney, lung, prostate, thyroid, and multiple myeloma [2, 3]. The management of metastatic spinal disease aims at pain control, maintenance or restoration of neurologic function and stability . Standard treatments include radiation therapy, chemotherapy and surgery. Minimally invasive therapeutic options, including kyphoplasty and radiofrequency ablation have recently been introduced for the treatment of painful spinal metastases. Percutaneous kyphoplasty is a fluoroscopic guided procedure that consists of percutaneous insertion of a balloon, which creates a cavity followed by intravertebral installation of PMMA. It can be used in both benign spinal disorders such as osteoporotic or traumatic fractures and malignant lesions such as metastases [5, 6]. It provides significant pain relief as well as reinforcement and stabilization of the bone . Radiofrequency ablation (RFA) is a relatively new method for the treatment of painful bone metastases. It was initially introduced for the treatment of osteoid osteoma  and then became an important alternative and safe method in the treatment of metastatic liver, renal and lung tumors [9–11].
The aim of this article is to present the feasibility of performing the combined RFA and balloon kyphoplasty (BKP) in 3 patients with painful spinal metastatic disease in one session.
Materials and methods
Three patients with painful metastatic foci in the spine were included in the study which was in accordance with the guidelines of the Helsinki Declaration and informed consent was obtained in each case.
The preoperatively referred VAS and the Oswestry disability index (ODI) were 6 and 66% respectively. The quantity of the preoperative analgesic therapy was registered. According to the classification of Tomita et al. , the patient had a score of 3, justifying a long term therapy. In consensus with the haematologists, a combined RFA and BKP of L4 vertebra was performed (Fig 3b) (see the surgical technique). The radiofrequency electrode was introduced two times in order to reach a larger necrotic area. The volume of the injected PMMA cement was 4 ml. An increase in 15% of the mid vertebral body height was observed. The histological examination confirmed the diagnosis of plasmacytoma. No complications related to procedure were observed. Postoperatively, the VAS and and Oswestry scores were 1% and 28% respectively and the patient did not need any additional analgesic therapy. In the 7-months follow-up, the patient was free of pain, the primary disease being stable with VAS and ODI being 2% and 40% respectively.
A 64-year-old man with a known liver cancer diagnosed 6 months ago, was presented to our clinic with severe pain in the lower thoracic region, deteriorating at night without any neurological deficit. He was neurologically intact. His medical history revealed a stable coronary heart disease. Histologically, the tumor was characterized as a hepatocellular carcinoma with moderate growth complicated with a treatable lung metastasis during the investigation after hospitalization. According to the classification of Tomita et al. , the patient with 6 points in the scoring system, was an eligible candidate for a palliative surgery, aiming at short-term local control. Preoperatively his VAS score was 8 and his Oswestry low back pain disability questionnaire 84%.
Immediately post-operatively, the VAS score was 4 and the need for painkillers was drastically reduced. No complications related to the procedure were observed. The VAS and the ODI at the 3-months follow-up were 2 and 52% respectively. The patient died 6 months after treatment from complications related to portal hypertension, being neurogically intact.
Increases of 6% and 12% were measured respectively for anterior and middle wall of T12 vertebra and 10% and 18% were measured respectively for anterior and middle wall of L1 vertebra. 13° restoration of the kyphotic angle was observed.
An asymptomatic intravenous cement extravasation from L2 vertebra (fig 6a) was observed. The patient presented a low-grade fever (<38°C) for two days post-operatively without any additional symptoms and signs of infection.
The directly post-operatively VAS score was 4 whereas in the 6-month follow-up the VAS and Oswestry scores were 2% and 36% respectively, without any consumption of analgesics.
Spinal complications of osseous metastatic disease may have detrimental effects on the quality of life of cancer patients. The treatment of patients with symptomatic metastatic spinal disease is performed in order to relieve the pain and to preserve or restore the neurological function. Cure is not usually a realistic expectation as the life expectancy is often relatively short with medial survival ranging from 4 to 15 months in different series [12–14]. The decision to provide surgical treatment is complex and debatable. Many authors believe that patients with a good prognosis benefit from radical surgical treatment . For preoperative evaluation we have used the classification of Tomita et al. namely the grade of malignancy and the presence of bone metastases and/or visceral metastases . Many authors find it simple to use in the management of spinal metastases . The anterior approach remains the "gold standard", but a posterior approach might be obligatory for certain patients [12, 15].
In this group of patients, an aggressive surgical attitude may be associated with substantial complications further classified as surgical (e.g., wound infections, haematomas, cerebrospinal fluid fistulas), instrumentation failures (broken, misplaced, migrated), medical (cardiovascular, pulmonary, nutritional), and neurologic (i.e., neurologic deterioration) . Currently, new evolving surgical techniques have enabled spinal surgeons to provide safe and improved management to the overall disease. Among the latter, RFA and vertebral body augmentation (vertebroplasty and kyphoplasty) have been employed for the treatment of spinal metastatic tumors with good results [17, 18].
The term "ablation" refers to the local destruction of the tumor by the means of application of either chemical agents (ethanol, acetic acid), or local deposition of some form of energy (radiofrequency, cryoablation, microwave, laser, and ultrasound). RFA is described in the literature as a safe and effective therapy to enhance the local control of malignant disease . In tumoral spine disease, indications for BKP include compression fractures from multiple myeloma and metastatic disease, particularly when conservative treatment has failed. Contraindications for BKP may include: (1) uncorrectable coagulopathy (2) pain unrelated to vertebral collapse 3) osteoblastic metastasis 4) severe iodine allergy 5) technically not feasible tumoral vertebral lesion [19, 20].
Kyphoplasty offers theoretical advantages over vertebroplasty regarding the restoration of the collapsed vertebral height and the reduction of the possibility of symptomatic extravasation [19–21]. Additionally, in extensive osteolytic lesion, the eggshell kyphoplasty technique minimizes the possibility of symptomatic leakage into the spinal cord and the neuronal foramina [21, 22]. However nowadays, there is no definitive conclusion about which technique is preferable because of the lack of sufficiently randomly controlled trials.
The aim of the combination of the RFA with kyphoplasty is threefold; firstly, to achieve a reduction of pain. The radiofrequency has a destructive effect over the sensory nerve fibers in the periosteum, which could result in an inhibition of the pain transmission . In addition, PMMA which has a mechanically stabilizing effect plays an important role in pain score improvement.
Secondly, to reinforce the antitumoral effect. RFA has a strong catabolic effect on tumor cells that are producing nerve-stimulating cytokines such as tumor necrosis factor-alpha (TNF-α), interleukins (IL-1 and IL-6), resulting in inhibition of osteoclast activity. PMMA has a direct toxic effect on the neoplasic cells due to its chemical and thermal properties [20, 21, 24].
Thirdly, the combination of the vertebral body augmentation matched with the antitumoral effect, might prevent a potential neurologic impairment secondary to a further collapse of the vertebra [8, 21].
In addition, RFA, which causes vascular necrosis and thrombosis in highly vascularized metastatic tumors, might reduce the risk of symptomatic vascular leakage during the cement augmentation.
To the best of our knowledge, the combination of RFA with BKP has not been described previously for the treatment of metastatic spinal fractures. In this limited number of patients, a significant reduction in pain scores and improvement in quality of life following the treatment with RFA and kyphoplasty for painful spinal metastases was noted. An associated significant reduction in opioid requirements was also noted at 3 and 6 months postoperatively.
Other studies have shown an important improvement in the Oswestry Disability Index (ODI) and VAS score in patients treated with kyphoplasty for osteolytic compression fractures resulting from multiple myeloma [25, 26].
No leakage of cement was seen intraoperatively or in the post-operatively radiological examinations. Kyphoplasty has a lower rate of cement leakage than vertebroplasty making the cement augmentation safer [20, 27, 28]. A recently updated meta-analysis reported a range of leakage after BKP (balloon kyphoplasty) up to 21.8% however the range of leakage after vertebroplasty series was estimated to be from 2% to 67% .
Pflugmacher et al. report 12% of cement leakage after 99 BKP procedures in patients with spinal metastatic disease . Importantly, the incidence of intravenous leaks and systemic embolization are similar for both procedures [28, 29, 31]. Naturally, the safety of the procedure has a crucial importance in these patients with an already aggravated medical situation. We applied the egg-shell technique in order to minimize the cement leakage through the involved anterior or lateral wall and in case of serious defect of the posterior wall, the placement of the PMMA is performed very carefully after 10 min of preparation and under continued fluoroscopic image in order to avoid the symptomatic extravasations.
In our study BKP was associated with a partial restoration of the vertebral height and kyphotic angle post-operatively and in the 3-month period of follow-up. However, height restoration and kyphotic correction are not the first priority in this group of patients. Recently, Liu et al. have demonstrated that BK is more effective in vertebral body augmentation than vertebroplasty . In an another study the improved radiographic outcomes of vertebral height restoration were observed to return to the pre-operative levels 12 months after the operation for metastatic spine disease .
After RFA, a considerable reduction of pain and improvement in the quality of life, as well as a decrease in the use of analgesic medications, is reported [24, 32, 33]. But, we were unable to find any histopathologic documentation of the antitumoral action of the RF. A rate of 10% of complications occurred during the RFA for liver lesions was reported . In spinal ablation the rate of complication is unknown. No complications including neurological structure damage, skin burns, infection or hemorrhage, related to RFA , were observed intra-operatively or early post-operatively in patients presented herein. We have not observed postoperatively the so-called post-ablation syndrome consisting of low-grade fever, myalgias, and malaise for up to 1 week after the procedure.
In the spine, RFA may be contraindicated due to the close relationship with the neural structures [24, 33, 34]. It has been suggested, and we adopted this approach, that the placement of the probe in the center of the vertebral body is a safe way to minimize such complications at the shortest distance from the spinal cord 1 cm [33, 34]. In order to enlarge the coagulation area, we placed the electrode twice into each involved vertebra. The histopathological examination in the third case demonstrated that RFA is efficient in inducing tumoral cells necrosis. The consequent toxic effect of PMMA during BKP acts synergically in tumoral cells necrosis.
To minimize the cytotoxic effects of the high temperature, we used an internally cooled electrode. The cerebrospinal fluid space itself plays a protective role against neurotoxicity . Normal saline (0.9%) infusion has been shown to be effective in enlarging the area of necrosis during ablation, acting as a liquid electrode with greater conductivity than that of blood and soft tissues. Furthermore, electrical conductivity is increased even more using a highly concentrated NaCl solution (6-36%) [5, 35].
The limitations of this case series study is the small number of patients, short follow-up and, as a new technical purpose, the absence of clear indications. Spinal secondaries in Myeloma Multipla and the presence of anterior location without extended soft tissue involvement may be a possible indication. Neurological involvement and the presence of a tumoral lesion approximately 1 cm from the spinal cord would be a contraindication to this technique.
The combined image-guided RFA with BKP is a safe, technically feasible, surgical technique, well tolerated by patients, for the treatment of the pathological fractures of the spine. Future prospective studies with larger series and longer follow-up are needed for evaluation of the safety and cost-efficacy of this combined technique.
Written informed consent was obtained from the patients for publication of this case series and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Harrington K: Metastatic tumors of the spine: diagnosis and treatment. J Am Acad Orthop Surg. 1993, 1: 76-86.Google Scholar
- Schaberg J, Gainor BJ: A profile of metastatic carcinoma of the spine. Spine. 1985, 10: 19-20. 10.1097/00007632-198501000-00003.View ArticlePubMedGoogle Scholar
- Wong DA, Fornasier VL, MacNab I: Spinal metastases: the obvious, the occult, and the impostors. Spine. 1990, 15: 1-4. 10.1097/00007632-199001000-00001.View ArticlePubMedGoogle Scholar
- Boriani S, Biagini R, De Iure F, Bertoni F, Malaguti MC, Di Fiore M, Zanoni A: En bloc resections of bone tumors of the thoracolumbar spine: A preliminary report on 29 patients. Spine. 1996, 21: 1927-1931. 10.1097/00007632-199608150-00020.View ArticlePubMedGoogle Scholar
- Goldberg SN, Ahmed M, Gazelle GS, Kruskal JB, Huertas JC, Halpern EF, Oliver BS, Lenkinski RE: Radiofrequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation- phantom and porcine liver study. Radiology. 2001, 219: 157-65.View ArticlePubMedGoogle Scholar
- Pflugmacher R, Beth P, Schroeder RJ, Schaser KD, Melcher I: Balloon kyphoplasty for the treatment of pathological fractures in the thoracic and lumbar spine caused by metastasis: one-year follow-up. Acta Radiol. 2007, 48: 89-95. 10.1080/02841850601026427.View ArticlePubMedGoogle Scholar
- Lieberman IH, Dudeney S, Reinhardt MK, Bell G: Initial outcome and efficacy of "kyphoplasty" in the treatment of painful osteoporotic vertebral compression fractures. Spine. 2001, 26: 1631-8. 10.1097/00007632-200107150-00026.View ArticlePubMedGoogle Scholar
- Rosenthal DI, Alexander A, Rosenberg AE, Springfield D: Ablation of osteoid osteomas with a percutaneously placed electrode: a new procedure. Radiology. 1992, 183: 29-33.View ArticlePubMedGoogle Scholar
- Dupuy DE, Hong R, Oliver B, Goldberg SN: Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. AJR Am J Roentgenol. 2000, 175: 1263-6.View ArticlePubMedGoogle Scholar
- Goldberg SN, Grassi JC, Cardella FJ, Charboneau JW, Dodd GD, Dupuy DE, Gervais D, Gillams AR, Kane RA, Lee FT, Livraghi T, McGahan J, Phillips DA, Rhim H, Silverman SG, Society of Interventional Radiology Technology Assessment Committee: Image -guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2005, 16: 765-78.View ArticlePubMedGoogle Scholar
- Jansen MC, van Duijnhoven FH, van Hillegersberg R, Rijken A, van Coevorden F, Sijp van der J, Prevoo W, van Gulik TM: Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. Br J Surg. 2005, 92: 1248-54. 10.1002/bjs.5059.View ArticlePubMedGoogle Scholar
- Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T: Surgical strategy for spinal metastases. Spine. 2001, 26: 298-306. 10.1097/00007632-200102010-00016.View ArticlePubMedGoogle Scholar
- Solberg A, Bremnes RM: Metastatic spinal cord compression: diagnostic delay, treatment, and outcome. Anticancer Res. 1999, 19: 677-684.PubMedGoogle Scholar
- Weigel B, Maghsudi M, Neumann C, Kretschmer R, Müller FJ, Nerlich M: Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life. Spine. 1999, 24: 2240-46. 10.1097/00007632-199911010-00012.View ArticlePubMedGoogle Scholar
- Singh K, Samartzis D, Vaccaro AR, Andersson GB, An HS, Heller JG: Current concepts in the management of metastatic spinal disease: The role of minimally-invasive approaches. J Bone Joint Surg Br. 2006, 88: 434-42. 10.1302/0301-620X.88B4.17282.View ArticlePubMedGoogle Scholar
- Sundaresan N, Rothman A, Manhart K, Kelliher K: Surgery for solitary metastases of the spine. rationale and results of treatment. Spine. 2002, 27: 1802-1806. 10.1097/00007632-200208150-00021.View ArticlePubMedGoogle Scholar
- Dupuy DF, Goldberg SN: Image-guided radiofrequency tumor ablation: challenges and opportunities. J Vasc Interv Radiol. 2001, 12: 1135-48. 10.1016/S1051-0443(07)61670-4.View ArticlePubMedGoogle Scholar
- Rao RD, Singrakhia MD: Painful osteoporotic vertebral fracture: Pathogenesis, evaluation, and roles of vertebroplasty and kyphoplasty in its management. J Bone Joint Surg Am. 2003, 85: 2010-22.PubMedGoogle Scholar
- Fourney DR, Schomer DF, Nader R, Chlan-Fourney J, Suki D, Ahrar K, Rhines LD, Gokaslan ZL: Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg. 2003, 98: 21-30. 10.3171/jns.2003.98.1.0021.View ArticlePubMedGoogle Scholar
- Khanna AJ, Neubauer P, Togawa D, Kay Reinhardt M, Lieberman IH: Kyphoplasty and vertebroplasty for the treatment of spinal metastases. Supportive Cancer Therapy. 2005, 3: 21-25. 10.3816/SCT.2005.n.021.View ArticlePubMedGoogle Scholar
- Gaitanis IN, Hadjipavlou AG, Katonis PG, Tzermiadianos MN, Pasku DS, Patwardhan AG: Balloon kyphoplasty for the treatment of pathological vertebral compressive fractures. Eur Spine J. 2005, 14: 250-60. 10.1007/s00586-004-0767-4.PubMed CentralView ArticlePubMedGoogle Scholar
- Greene DL, Isaac R, Neuwirth M, Bitan FD: The eggshell technique for prevention of cement leakage during kyphoplasty. J Spinal Disord Tech. 2007, 20: 229-32. 10.1097/01.bsd.0000211276.76024.30.View ArticlePubMedGoogle Scholar
- Mannion RJ, Woolf CJ: Pain mechanisms and management: a central perspective. Clin J Pain. 2000, 16;: S144-156.View ArticlePubMedGoogle Scholar
- Thanos L, Mylona S, Galani P, Tzavoulis D, Kalioras V, Tanteles S, Pomoni M: Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol. 2008, 37: 189-94. 10.1007/s00256-007-0404-5.PubMed CentralView ArticlePubMedGoogle Scholar
- Dudeney S, Lieberman IH, Reinhardt MK, Hussein M: Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma. J Clin Oncol. 2002, 20: 2382-7. 10.1200/JCO.2002.09.097.View ArticlePubMedGoogle Scholar
- Lane JM, Hong R, Koob J, Kiechle T, Niesvizky R, Pearse R, Siegel D, Poynton AR: Kyphoplasty enhances function and structural alignment in multiple myeloma. Clin Orthop Relat Res. 2004, 426: 49-53. 10.1097/01.blo.0000131642.96984.74.View ArticlePubMedGoogle Scholar
- Hadjipavlou AG, Tzermiadianos MN, Katonis PG, Szpalski M: Percutaneous vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures and osteolytic tumours. J Bone Joint Surg Br. 2005, 87: 1595-604. 10.1302/0301-620X.87B12.16074.View ArticlePubMedGoogle Scholar
- Hulme PA, Krebs J, Ferguson SJ, Berlemann U: Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine. 2006, 31: 1983-2001. 10.1097/01.brs.0000229254.89952.6b.View ArticlePubMedGoogle Scholar
- Taylor RS, Fritzell P, Taylor RJ: Balloon kyphoplasty in the management of vertebral compression fractures: an updated systematic review and meta-analysis. Eur Spine J. 2007, 16: 1085-100. 10.1007/s00586-007-0308-z.PubMed CentralView ArticlePubMedGoogle Scholar
- Pflugmacher R, Taylor R, Agarwal A, Melcher I, Disch A, Haas NP, Klostermann C: Ballon kyphoplasty in the treatment of metastatic disease of the spine: a 2-year prospective evaluation. Eur Spine J. 2008, 17: 1042-48. 10.1007/s00586-008-0701-2.PubMed CentralView ArticlePubMedGoogle Scholar
- Barrocas AM, Eskey CJ, Hirsch JA: Vertebral augmentation in osteoporotic fractures. Injury. 2007, 38: 88-96. 10.1016/j.injury.2007.08.016.View ArticleGoogle Scholar
- Liu JT, Liao WJ, Tan WC, Lee JK, Liu CH, Chen YH, Lin TB: Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporos Int. 2009,Google Scholar
- Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Atwell TD, Farrell MA, Welch TJ, Maus TP: Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol. 2006, 35: 1-15. 10.1007/s00256-005-0003-2.View ArticlePubMedGoogle Scholar
- Nakatsuka A, Yamakado K, Maeda M, Yasuda M, Akeboshi M, Takaki H, Hamada A, Takeda K: Radiofrequency ablation combined with bone cement injection for the treatment of bone malignancies. J Vasc Interv Radiol. 2004, 15: 707-12.View ArticlePubMedGoogle Scholar
- Buy X, Basile A, Bierry G, Cupelli J, Gangi A: Saline-infused bipolar radiofrequency ablation of high-risk spinal and paraspinal neoplasms. AJR Am J Roentgenol. 2006, 186: S322-62. 10.2214/AJR.05.0265.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.